Clinical stage III cutaneous melanoma ajcc V8
Clinical trials for Clinical stage III cutaneous melanoma ajcc V8 explained in plain language.
Never miss a new study
Get alerted when new Clinical stage III cutaneous melanoma ajcc V8 trials appear
Sign up with your email to follow new studies for Clinical stage III cutaneous melanoma ajcc V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo tackles tough melanoma
Disease control Stopped earlyThis phase II trial is testing whether a combination of two drugs, rigosertib and pembrolizumab, can help people with advanced melanoma that no longer responds to standard immunotherapy. The study involves 7 participants with unresectable or metastatic melanoma. The goal is to se…
Matched conditions: CLINICAL STAGE III CUTANEOUS MELANOMA AJCC V8
Phase 2 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Experimental triple therapy for advanced cancers shows early promise but trial halted
Disease control Stopped earlyThis early-phase trial tested the drug plinabulin combined with radiation and immunotherapy in 19 people with advanced cancers (like lung, bladder, or melanoma) that had stopped responding to standard immunotherapy. The goal was to see if the combination was safe and could shrink…
Matched conditions: CLINICAL STAGE III CUTANEOUS MELANOMA AJCC V8
Phase 1/2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Engineered virus takes on Hard-to-Treat melanoma
Disease control Stopped earlyThis early-stage trial tested a modified virus (VSV-IFNbetaTYRP1) in 12 patients with advanced melanoma that had spread or could not be removed by surgery. The virus was designed to infect and kill melanoma cells while also boosting the immune system's attack. The main goals were…
Matched conditions: CLINICAL STAGE III CUTANEOUS MELANOMA AJCC V8
Phase 1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Experimental Lymph-Node injection for skin cancer trial halted early
Disease control Stopped earlyThis early-phase trial tested whether giving the immunotherapy drug STI-3031 directly into the lymph nodes or vessels (using a special device) is safe for people with in-transit melanoma, a type of skin cancer that spreads through lymph channels. Only 3 people took part before th…
Matched conditions: CLINICAL STAGE III CUTANEOUS MELANOMA AJCC V8
Phase 1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC